Thyrocare Technologies Limited
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
What Thyrocare files
- Others82
- Investor Meet26
- Important23
- Updates18
- Insider Trade13
- Board Meeting10
Thyrocare Technologies Limited disclosed some pledging/unpledging activity. Please check pdf for more details.
Thyrocare's promoter, Docon Technologies, has released a pledge on 1.75 crore equity shares of the company. Previously, Docon had pledged its entire 60.92% stake as security for Non-Convertible Debentures (NCDs) issued by its holding company, API Holdings. This move reduces Docon's encumbered (pledged) shareholding in Thyrocare from 60.92% to 49.93%....
The number of pledged shares of Thyrocare Technologies by its promoter, Docon Technologies, remains unchanged. A total of 9,69,69,696 shares (60.93% of Thyrocare's capital) are still encumbered. This update follows the partial redemption of Series 1 Non-Convertible Debentures (NCDs) worth 120 Cr by Docon's parent company, API Holdings. This redemption...
Thyrocare's promoter, Dr. Arokiaswamy Velumani, restructured an existing pledge on Feb 25, 2022. This involved a simultaneous creation and release of encumbrance on 1.35 million shares (2.54% of total share capital) with Edelweiss ARC, for security against an inter-corporate deposit by a promoter group company. For investors, the key takeaway...
Thyrocare Technologies Limited disclosed some pledging/unpledging activity. Please check pdf for more details.